Wyeth liability case advances in California
March 19th 2009California may be moving toward a new form of liability. The state Supreme Court declined to hear an appeal from Wyeth in a case the held the drug maker liable for injuries caused by generic versions of Reglan (metoclopramide) made by another manufacturer.
Bill would allow community pharmacies to negotiate with PBMs
March 3rd 2009In an effort to permit community pharmacies to negotiate better contracts, Reps. Anthony Weiner (D-NY) and Jerry Moran (R-KS) recently introduced legislation designed to level the playing field between community pharmacies and pharmacy benefit managers (PBMs).
NCPA, NACDS welcome AMP hearing postponement
February 27th 2009The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) applauded a decision by U.S. District Judge Royce C. Lamberth to postpone a February hearing about Medicaid Average Manufacturer Price (AMP).
Alabama pharmacists charged with illegally dispensing steroids
January 26th 2009Three pharmacy owners and four pharmacists were among 12 people recently indicted for participating in a conspiracy that dispensed and sold thousands of dosages of anabolic steroids ? including powerful veterinary steroids approved for animal use only ? to users throughout the United States.
Drug sales hampered by economy, free antibiotics
January 21st 2009The slumping U.S economy and government regulations will cause pharmacy sales to grow only around 1.3 percent rate in 2009, according to new research presented last week at the American Society for Automation in Pharmacy?s Industry and Technology Issues in St. Petersburg, Fla.
Eli Lilly to pay more than $800 million for off-label promotion of Zyprexa
January 20th 2009Eli Lilly and Co. has agreed to plead guilty to one misdemeanor violation of the Food, Drug, and Cosmetic Act and will pay more approximately $800 million for unproven marketing and promotional claims involving the antipsychotic medication Zyprexa.